#United States #Fort Myers #Florida Cancer #Press Ganey #Human Experience

Florida Cancer Specialists Achieves 2024 Press Ganey Award

Florida Cancer Specialists & Research Institute, known for its commitment to outstanding patient care, has been recognized as a 2024 Human Experience Guardian of Excellence Award winner by Press Ganey. This prestigious award honors healthcare organizations that excel in providing exceptional patient experiences, with FCS ranking within the top 1% of healthcare providers in the United States.

Established in 1984, FCS has grown to become a leading name in oncology, treating thousands of patients annually with a focus on compassion and state-of-the-art clinical practices. Dr. Lucio N. Gordan, President and Managing Physician, expressed his honor in serving patients and their families, highlighting the organization's commitment to enhancing patient well-being through every step of their treatment journey.

"At FCS, every interaction is meticulously focused on the patient experience," Dr. Gordan stated. He emphasized that the insights gained from Press Ganey’s partnership help in continuously refining FCS’s services to meet patient needs effectively. This dedication has been crucial, especially in light of the challenges posed by recent hurricanes, during which the FCS team showed resilience and adaptability, ensuring patient care remained uninterrupted.

Nathan H. Walcker, the Chief Executive Officer of FCS, echoed this sentiment. He noted that achieving such high rankings amidst external challenges demonstrates the unwavering commitment of the 250 physicians and over 4,700 staff members to delivering world-class cancer care. Walcker highlighted that the team’s dedication to patient safety and care quality truly sets FCS apart in the landscape of healthcare.

The recognition by Press Ganey is a testament to FCS's efforts in prioritizing not just treatment, but the overall patient experience. Rumored to be initiated from patient feedback, Press Ganey demonstrates its effectiveness through proactive measures that connect patients' needs with high-standard healthcare services. The CEO of Press Ganey, Patrick T. Ryan, praised FCS for its leadership in improving patient experiences that translate into tangible outcomes for the community.

FCS’s long-standing reputation hinges on its innovative clinical research, which gives patients access to more clinical trials than any other private oncology practice in Florida. The practice plays a pivotal role in studying new cancer drugs that have recently been approved in the U.S. FCS has successfully received the Clinical Trials Participation Award from the American Society of Clinical Oncology (ASCO), further establishing its credibility in the oncology field.

Innovative treatment options such as targeted therapies, genomic-based treatments, and immunotherapy are hallmarks of FCS’s approach. Their dedication to clinical excellence and compassionate care reflects through numerous national accolades and rankings as Top Doctors by U.S. News & World Report. Their success story illustrates how a focus on patient-centered care can lead to recognition at a national level, while concurrently reinforcing their core mission - improving the lives of individuals battling cancer.

FCS's commitment remains unwavering as they continue to lead in advanced treatment modalities and research, striving to raise the standards in patient care, while ensuring each patient's experiences are positive and tailored to their unique journeys.

As FCS prepares for future challenges, they remain dedicated to evolving healthcare experiences, aiming to consistently turn insights into actionable solutions for enhancing patient relationships and outcomes.

For more information about Florida Cancer Specialists & Research Institute and their commitment to excellence in care, visit FLCancer.com.